{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:52:34Z","timestamp":1774291954123,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.bpg.2010.02.008","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T06:07:07Z","timestamp":1269238027000},"page":"133-141","source":"Crossref","is-referenced-by-count":54,"title":["Adverse effects of drugs on small intestine and colon"],"prefix":"10.1016","volume":"24","author":[{"given":"Zeino","family":"Zeino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Sisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvar","family":"Bjarnason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.02.008_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cdip.2006.05.002","article-title":"Drug-induced pathology in the large intestine","volume":"12","author":"Geboes","year":"2006","journal-title":"Curr Diagn Pathol"},{"key":"10.1016\/j.bpg.2010.02.008_bib2","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","article-title":"Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs","volume":"327","author":"Allison","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.02.008_bib5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0016-5085(88)90568-9","article-title":"Clinico-pathological features of nonsteroidal antiinflammatory drug induced small intestinal strictures","volume":"94","author":"Bjarnason","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","article-title":"Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study","author":"Maiden","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.02.008_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00535-009-0040-z","article-title":"Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy","volume":"44","author":"Endo","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM199007123230216","article-title":"Colonic ulceration and bleeding during diclofenac therapy","volume":"323","author":"Carson","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.02.008_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00004836-199301000-00020","article-title":"Diaphragm disease of the ascending colon associated with sustained release diclofenac","volume":"16","author":"Halter","year":"1993","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0016-5085(91)90291-R","article-title":"Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report","volume":"100","author":"Huber","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.43.4.506","article-title":"Intestinal permeability and inflammation in patients on NSAIDs","volume":"43","author":"Sigthorsson","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.02.008_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(05)75962-6","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/367215a0","article-title":"Towards a better aspirin","volume":"367","author":"Vane","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2010.02.008_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(95)91782-9","article-title":"NSAIDs, COX-2 inhibitors, and the gut","volume":"346","author":"Vane","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0707176","article-title":"Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin","author":"Lichtenberger","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpg.2010.02.008_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm0295-154","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury","volume":"1","author":"Lichtenberger","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2010.02.008_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.1780391208","article-title":"Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation","volume":"39","author":"Mahmud","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpg.2010.02.008_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/bega.2001.0229","article-title":"Pathogenesis of NSAID-induced gastroduodenal mucosal injury","volume":"15","author":"Wallace","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","article-title":"A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy","volume":"128","author":"Maiden","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/gut.33.9.1204","article-title":"Metronidazole reduces inflammation and blood loss in NSAID enteropathy","volume":"33","author":"Bjarnason","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.02.008_bib23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780370806","article-title":"Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: effect of sulphasalazine and other disease modifying drugs","volume":"37","author":"Hayllar","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpg.2010.02.008_bib24","first-page":"A669","article-title":"Misoprostol in the treatment of NSAID-induced enteropathy: a double blind, placebo-controlled, parallel group study","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(87)91075-0","article-title":"Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs","volume":"2","author":"Bjarnason","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulcer disease","volume":"28","author":"Armstrong","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.02.008_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/bjs.1800780218","article-title":"Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case control study","volume":"78","author":"Campbell","year":"1991","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2010.02.008_bib28","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.295.6608.1238","article-title":"Steroids, non-steroidal anti-inflammatory drugs and serious complications of diverticular disease","volume":"295","author":"Corder","year":"1987","journal-title":"Br Med J"},{"key":"10.1016\/j.bpg.2010.02.008_bib29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(78)92385-1","article-title":"Acute perforation of colonic diverticula associated with short term indomethacin","volume":"2","author":"Coutrot","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib30","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","article-title":"The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis","volume":"103","author":"Cornish","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/gut.37.5.668","article-title":"Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease","volume":"37","author":"Godet","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.02.008_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/gut.27.1.59","article-title":"Investigation of auranofin-induced diarrhoea","volume":"27","author":"Behrens","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.02.008_bib33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1157\/13128308","article-title":"Perforation of hollow viscera associated with cocaine use","volume":"31","author":"Tall\u00f3n Aguilar","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.02.008_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jamcollsurg.2008.02.039","article-title":"Crack cecum","volume":"207","author":"Trinca","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.bpg.2010.02.008_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s10350-005-0195-5","article-title":"Enterocolitis associated with cocaine use","volume":"48","author":"Ellis","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpg.2010.02.008_bib36","first-page":"102","article-title":"Proctitis following the prolonged use of dextropropoxyphene and paracetamol suppositories: the risk persists despite change of excipient","volume":"14","author":"Marteau","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.bpg.2010.02.008_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2007-1018490","article-title":"Ergotamine-induced colitis","volume":"17","author":"W\u00f6rmann","year":"1985","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2010.02.008_bib38","first-page":"321","article-title":"Necrotizing anorectitis and proctitis after long term utilization of a dextropropoxyphene and paracetamol association in suppositories, 7 cases","volume":"37","author":"Vincens","year":"1982","journal-title":"Therapie"},{"key":"10.1016\/j.bpg.2010.02.008_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11894-999-0040-4","article-title":"Cystic fibrosis colonopathy","volume":"1","author":"Lloyd-Still","year":"1999","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bpg.2010.02.008_bib40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MCG.0b013e318033df5d","article-title":"Isotretinoin-associated pan-enteritis","volume":"42","author":"Spada","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/00365520410003326","article-title":"The G.U.T. of gut","volume":"39","author":"Bjarnason","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/00365520701452241","article-title":"Effects of five different alcoholic drinks on patients with Crohn's disease","volume":"42","author":"Hey","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.02.008_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Besselink","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib44","first-page":"342","article-title":"Small bowel obstruction caused by intramural hemorrhage secondary to anticoagulant therapy","volume":"71","author":"Cheng","year":"2008","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.bpg.2010.02.008_bib45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1200\/JCO.1987.5.10.1559","article-title":"A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma","volume":"5","author":"Petrelli","year":"1987","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib46","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1995.13.6.1303","article-title":"Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study","volume":"13","author":"Leichman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1995.13.1.210","article-title":"Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients","volume":"13","author":"Abigerges","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib48","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1998.16.8.2745","article-title":"Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment","volume":"16","author":"Saliba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.02.008_bib50","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.02.008_bib51","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1158\/1078-0432.CCR-04-0746","article-title":"Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities","volume":"10","author":"Messersmith","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.bpg.2010.02.008_bib52","article-title":"Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results","volume":"24","author":"Czito","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.1993.11.1.148","article-title":"Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial","volume":"11","author":"Cascinu","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1008372228462","article-title":"Octreotide in the treatment of severe chemotherapy-induced diarrhea","volume":"12","author":"Zidan","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib55","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0016-5085(88)90404-0","article-title":"Vincristine and gastrointestinal transit","volume":"95","author":"Sharma","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.02.008_bib56","first-page":"270","article-title":"Gastrointestinal emergencies in the critically ill cancer patient","volume":"27","author":"Schnoll-Sussman","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bpg.2010.02.008_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<409::AID-CNCR7>3.0.CO;2-J","article-title":"Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature","volume":"83","author":"Avigan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2010.02.008_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/1097-0142(19920101)69:1<17::AID-CNCR2820690106>3.0.CO;2-X","article-title":"Neutropenic enterocolitis. Clinical diagnosis and treatment","volume":"1","author":"Wade","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2010.02.008_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:40:03Z","timestamp":1558957203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1521691810000223"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.02.008","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}